HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Himanshi Kapoor Selected Research

Frataxin

3/2024Generation and characterization of iPSC lines from Friedreich's ataxia patient (FRDA) with GAA.TTC repeat expansion in the Frataxin (FXN) gene's first intron (IGIBi016-A) and a non-FRDA healthy control individual (IGIBi017-A).
12/2023Generation and characterization of two human iPSC lines, IGIBi014-A and IGIBi015-A, from Friedreich's ataxia (FRDA) patients with pathogenic (GAA/TTC)n repeat expansion in first intron of the Frataxin (FXN) gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Himanshi Kapoor Research Topics

Disease

2Friedreich Ataxia (Friedreich's Ataxia)
03/2024 - 12/2023
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
05/2024
1Neurodegenerative Diseases (Neurodegenerative Disease)
05/2024
1Fibrosis (Cirrhosis)
12/2023
1Body Weight (Weight, Body)
12/2023
1Pneumonia (Pneumonitis)
12/2023
1Pulmonary Fibrosis (Fibrosing Alveolitis)
12/2023
1Respiratory Tract Diseases (Respiratory Tract Disease)
12/2023
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2022
1Ataxia (Dyssynergia)
10/2022
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
10/2022
1Paraplegia (Spastic Paraplegia)
10/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2017
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2017

Drug/Important Bio-Agent (IBA)

2FrataxinIBA
03/2024 - 12/2023
15' Untranslated Regions (5' UTR)IBA
05/2024
1CollagenIBA
12/2023
1Fibronectins (Fibronectin)IBA
12/2023
1MicroRNAs (MicroRNA)IBA
12/2023
1Vehicle Emissions (Emissions, Vehicle)IBA
12/2023
1Sirtuin 1IBA
12/2023
1ResveratrolIBA
12/2023
1KinesinsIBA
10/2022
1DystrophinIBA
10/2022
1ErbB Receptors (EGF Receptor)IBA
01/2017
1oroselolIBA
01/2017
1nardostachysinIBA
01/2017
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2017
1Cyclin-Dependent Kinase 2IBA
01/2017
1nardosinoneIBA
01/2017

Therapy/Procedure

1Therapeutics
01/2017